Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.8%

4 terminated/withdrawn out of 223 trials

Success Rate

96.9%

+10.4% vs industry average

Late-Stage Pipeline

18%

40 trials in Phase 3/4

Results Transparency

4%

5 of 127 completed trials have results

Key Signals

28 recruiting5 with results

Enrollment Performance

Analytics

N/A
47(44.3%)
Phase 4
27(25.5%)
Phase 2
13(12.3%)
Phase 3
13(12.3%)
Phase 1
6(5.7%)
106Total
N/A(47)
Phase 4(27)
Phase 2(13)
Phase 3(13)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (223)

Showing 20 of 223 trials
NCT02083835Recruiting

PAIN OUT: Improvement in Postoperative PAIN OUTcome

Role: collaborator

NCT07124676Recruiting

Prospective Study Comparing Two Classification Systems for Second-degree Vaginal Tears During Spontaneous Childbirth to Assess Their Ability to Predict Postpartum Complications.

Role: lead

NCT07425912Completed

Real-World Evaluation of TouchCare Nano in Pediatric Type 1 Diabetes

Role: lead

NCT06991816Active Not Recruiting

The Brain&Senses Study

Role: lead

NCT03360981Phase 4Completed

Epicardial Fat and Clinical Outcomes After Coronary Artery Bypass Grafting in Diabetics vs. Non Diabetics

Role: lead

NCT03439592Completed

Analysis of the Microbiota and STEMI

Role: lead

NCT06668610Not ApplicableRecruiting

A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia

Role: lead

NCT07544290Enrolling By Invitation

Autoimmune Hyperthyroidism in Prepubertal Children

Role: collaborator

NCT07478107Completed

Molecular Citology to Detect Free Cancer Cells in Peritoneal Fluid

Role: lead

NCT07366463Not ApplicableCompleted

Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD

Role: lead

NCT06718452Not ApplicableNot Yet Recruiting

Tinnitus and Treatment With umPEA-LUT

Role: lead

NCT07389265Phase 3Recruiting

Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer

Role: lead

NCT06409832Recruiting

RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment

Role: collaborator

NCT05903040Completed

Ditan Acute tReatments: Effectiveness and Tolerability (DART)

Role: collaborator

NCT05903027Recruiting

Gepant treAtments: EffectIveNess and tolERability (GAINER)

Role: collaborator

NCT06414044Active Not Recruiting

Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients

Role: collaborator

NCT07326124Phase 3Not Yet Recruiting

Stratification and Treatment in Early Psychosis Study -ASSIST

Role: collaborator

NCT07291609Recruiting

Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes

Role: collaborator

NCT06778564Phase 3Not Yet Recruiting

Stratification and Treatment in Early Psychosis Study - ENHANCE

Role: collaborator

NCT03884543Not ApplicableCompleted

Driving Pressure During General Anesthesia for Open Abdominal Surgery

Role: collaborator